IIT Roorkee researchers have developed a new drug candidate, Compound 3b, that restores antibiotics' effectiveness against "deadly" drug-resistant bacteria, as per an official release. "This breakthrough offers...promising solution to one of the world's most urgent health challenges," the team lead said. They designed the molecule to treat infections caused by superbug Klebsiella pneumoniae (Kp).